Provider 1982940862
Total Paid
$12.9M
$12,947,368
Total Claims
579K
Beneficiaries
408K
1.4 claims/patient
Avg Cost/Claim
$22
Monthly Spending Trend
Yearly Spending
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 30 distinct procedure codes. The top code (G0481 (Drug test, definitive, 8-14 drug classes)) accounts for 34% of total spending.
$4.3M
39K claims
$111.31
$64.72
Drug test, definitive, 8-14 drug classes
$4.3M
39K claims · 33.5%
$1.4M
37K claims
$37.87
$35.43
Drug test, presumptive, by chemistry analyzers
$1.4M
37K claims · 10.7%
$1.3M
16K claims
$82.11
$90.89
Drug test, definitive, 22+ drug classes
$1.3M
16K claims · 9.9%
$949K
29K claims
$33.25
$60.05
COVID-19 test, nucleic acid detection, CDC lab only
$949K
29K claims · 7.3%
$493K
16K claims
$30.04
$75.26
Drug test, definitive, 15-21 drug classes
$493K
16K claims · 3.8%
$312K
5,417 claims
$57.68
$26.72
Infectious agent detection, nucleic acid, not otherwise specified
$312K
5,417 claims · 2.4%
$187K
3,193 claims
$58.50
$37.56
Drug test, definitive, 1-7 drug classes
$187K
3,193 claims · 1.4%
$158K
2,755 claims
$57.19
$38.79
Infectious agent detection, amplified probe, multiple organisms
$158K
2,755 claims · 1.2%
$150K
16K claims · 1.2%
$143K
15K claims · 1.1%
$132K
15K claims · 1.0%
$131K
11K claims · 1.0%
$123K
16K claims · 1.0%
$123K
11K claims · 0.9%
$120K
15K claims · 0.9%
$120K
16K claims · 0.9%
$120K
15K claims · 0.9%
$117K
15K claims · 0.9%
$116K
15K claims · 0.9%
$112K
15K claims · 0.9%
$112K
16K claims · 0.9%
$108K
16K claims · 0.8%
$107K
16K claims
$6.77
$5.26
Benzodiazepine drug level, definitive method, each
$107K
16K claims · 0.8%
$106K
14K claims · 0.8%
$106K
9,921 claims
$10.64
$15.76
Infectious disease detection, COVID-19, antigen
$106K
9,921 claims · 0.8%
$103K
13K claims
$8.06
$5.78
Benzodiazepine drug assay by definitive method
$103K
13K claims · 0.8%
$95K
15K claims · 0.7%
$92K
7,651 claims · 0.7%
$89K
13K claims · 0.7%
$86K
7,552 claims · 0.7%